Gliomas are the most common primary malignant brain tumor. Over the last decade,
significant advances have been made in the molecular characterization of this tumor group …

Abstract World Health Organization (WHO) grade I astrocytomas include pilocytic
astrocytoma (PA) and subependymal giant cell astrocytoma (SEGA). As technologies in …

Neurofibromatosis Type 2 (NF2) is a rare autosomal dominant disorder characterized by the
development of benign tumors of the peripheral nervous system and the CNS, including …

Abstract Neurofibromatosis type 1 (NF1) is a genetic disorder associated with neurofibromin
1 (NF1) gene mutation, which generates an increased risk of variety of tumor types. The …

The immune system retains memory of current and past infections and can sense the
presence of cancer by elaborating autoantibodies to tumor proteins. In the presence of an …

Reproductive decisions after prenatal diagnosis in neurofibromatosis type 1: importance of
genetic counseling: Neurofibromatosis type 1 (NF1) is one of the most common autosomal …

Chapter 7 deals with neuroblastoma (NB) and related tumors. The specific genetic events
responsible for NB development have not been established, even though several changes …

Abstract Neurofibromatosis type 1 (NF1) is an autosomal dominant disease that affects the
development and growth of various tissues. NF1 is a major risk factor for the development of …

Work to date on the identification of predictive and prognostic markers in brain tumors
provide reason for both caution and optimism with respect to improvements in the diagnosis …

Two pathogenic NF1 gene mutations identified in DNA from a child with mild phenotype |
SpringerLink Skip to main content Advertisement SpringerLink Log in Menu Find a journal …